ECM2 | Extracellular matrix protein 2, female organ and adipocyte specific | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EHD2 | EH-domain containing 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ELOVL3 | ELOVL fatty acid elongase 3 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
FAM180B | Family with sequence similarity 180, member B | Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM47E-STBD1 | FAM47E-STBD1 readthrough | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
FMO2 | Flavin containing monooxygenase 2 (non-functional) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
FZD4 | Frizzled class receptor 4 | CD markers Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GABRE | Gamma-aminobutyric acid (GABA) A receptor, epsilon | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GALNT15 | Polypeptide N-acetylgalactosaminyltransferase 15 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GCOM1 | GRINL1A complex locus 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
GFPT2 | Glutamine-fructose-6-phosphate transaminase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GPD1 | Glycerol-3-phosphate dehydrogenase 1 (soluble) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
GPR146 | G protein-coupled receptor 146 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GSC | Goosecoid homeobox | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HAS1 | Hyaluronan synthase 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
HAS2 | Hyaluronan synthase 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
HCAR1 | Hydroxycarboxylic acid receptor 1 | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
HEPACAM | Hepatic and glial cell adhesion molecule | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
HRCT1 | Histidine rich carboxyl terminus 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
IGFBP6 | Insulin-like growth factor binding protein 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL2RA | Interleukin 2 receptor, alpha | Cancer-related genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
IL6 | Interleukin 6 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
INHBB | Inhibin, beta B | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
IRX6 | Iroquois homeobox 6 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
KANK4 | KN motif and ankyrin repeat domains 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCTD2 | Potassium channel tetramerization domain containing 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
KLB | Klotho beta | Predicted membrane proteins
| | | | | Tissue enhanced |
MDFI | MyoD family inhibitor | Predicted intracellular proteins
| | | | | Tissue enhanced |
MEDAG | Mesenteric estrogen-dependent adipogenesis | Predicted intracellular proteins
| | | | | Tissue enhanced |
MEOX1 | Mesenchyme homeobox 1 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
MINOS1-NBL1 | MINOS1-NBL1 readthrough | Predicted secreted proteins
| | | | | Tissue enhanced |
MT1A | Metallothionein 1A | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
MT1M | Metallothionein 1M | Predicted intracellular proteins
| | | | | Tissue enhanced |
MXRA8 | Matrix-remodelling associated 8 | Predicted membrane proteins
| | | | | Tissue enhanced |
MYOC | Myocilin, trabecular meshwork inducible glucocorticoid response | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NMB | Neuromedin B | Predicted secreted proteins
| | | | | Tissue enhanced |
NPR1 | Natriuretic peptide receptor 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
NXNL1 | Nucleoredoxin-like 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PALM2-AKAP2 | PALM2-AKAP2 readthrough | Predicted intracellular proteins
| | | | | Tissue enhanced |
PALMD | Palmdelphin | Predicted intracellular proteins
| | | | | Tissue enhanced |
PCOLCE2 | Procollagen C-endopeptidase enhancer 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
PDE3B | Phosphodiesterase 3B, cGMP-inhibited | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
PLAC9 | Placenta-specific 9 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PLXNA4 | Plexin A4 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PQLC2L | PQ loop repeat containing 2-like | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PROKR1 | Prokineticin receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PTX3 | Pentraxin 3, long | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RASL10B | RAS-like, family 10, member B | Predicted intracellular proteins
| | | | | Tissue enhanced |
RDH5 | Retinol dehydrogenase 5 (11-cis/9-cis) | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |